Perperas A, Karagiannakis D, Anagnostopoulos G, Tsirogiannis A, Panagiotakos D, Papadopoulos S, Tsagkaris M, Papasteriades C, Manolakopoulos S. Changes in serum interleukin 12 levels in hepatitis C patients following Pegylated Interferon-a2b plus Ribavirin treatment. Submitted.

Ladas SD. Dimitrios S. Karagiannakis, Jiannis Vlachogiannakos, Georgios Anastasiadis, Irini Vafiadis-Zouboulis &. Submitted.

Karagiannakis D, Filalithis P, Tsirogiannis M, Papasteriades C, Perperas A. Alterations of serum Interleukin 12 levels in hepatitis C patients, during Pegylated Interferon-$\alpha$2b plus Ribavirin treatment. Submitted.

Karagiannakis DS. Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease: High Hopes and Ongoing Challenges. 2025.

Tsitsou S, Adamantou M, Bali T, Saridaki A, Poulia K-A, Karagiannakis DS, Papakonstantinou E, Cholongitas E. Chrononutrition and MASLD—It is About Time (Restricted Feeding)! Authors' Reply. Alimentary Pharmacology & Therapeutics. 2025;61:1567–1568.

Tsitsou S, Adamantou M, Bali T, Saridaki A, Poulia K-A, Karagiannakis DS, Papakonstantinou E, Cholongitas E. Clarifying the Synergistic Mechanisms of Mediterranean Diet and Time-Restricted Feeding in MASLD Management—Authors' Reply. Alimentary Pharmacology & Therapeutics. 2025.

Tsitsou S, Bali T, Adamantou M, Saridaki A, Poulia K-A, Karagiannakis DS, Papakonstantinou E, Cholongitas E. Effects of a 12-Week Mediterranean-Type Time-Restricted Feeding Protocol in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Controlled Trial—The ‘CHRONO-NAFLD Project’. Alimentary Pharmacology & Therapeutics. 2025;61:1290–1309.

Papatheodoridi M, Paraskevopoulou S, Ioannidou P, Fytili P, Karagiannakis D, Cholongitas E, Vlachogiannakos I, Papatheodoridis G. SAT-300 The effect of antiviral therapy on the outcomes of baseline grey-zone (GZ) patients with HBeAg-negative chronic hepatitis B virus infection (CHBVe-). Journal of Hepatology. 2025;82:S800.

Papatheodoridi M, Sevastianos V, Zachou K, Christodoulou D, Koskinas I, Deutsch M, Alexopoulou A, Elefsiniotis I, Triantos C, Gigi E, et al. WED-304 HERACLIS\_BLV\_D: Increasing response rates during 2-year bulevirtide real-life therapy in chronic hepatitis D. Journal of Hepatology. 2025;82:S819–S820.

Karagiannakis DS, Stefanaki K, Paschou SA, Papatheodoridi M, Tsiodras S, Papanas N. Addressing the essentials of the recent guidelines for managing patients with metabolic dysfunction-associated steatotic liver disease. Hormones. 2024:1–8.

Papatheodoridi M, Paraskevopoulou S, Ioannidou P, Fytili P, Karagiannakis D, Cholongitas E, Vlachogiannakos I, Papatheodoridis G. CURRENT MANAGEMENT AND TREATMENT INDICATIONS OF BASELINE GREY-ZONE (GZ) PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B VIRUS INFECTION (CHBVE-) IN GREECE. In: HEPATOLOGY. Vol. 80. LIPPINCOTT WILLIAMS & WILKINS TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA …; 2024. pp. S197–S198.

Papatheodoridi M, Paraskevopoulou S, Ioannidou P, Fytili P, Karagiannakis D, Cholongitas E, Vlachogiannakos I, Papatheodoridis G. LONG-TERM OUTCOMES OF BASELINE GREY-ZONE (GZ) PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B VIRUS INFECTION (CHBVE-) IN GREECE. In: HEPATOLOGY. Vol. 80. LIPPINCOTT WILLIAMS & WILKINS TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA …; 2024. pp. S198–S198.

Karagiannakis DS, Stefanaki K, Petrea F, Zacharaki P, Giannou A, Michalopoulou O, Kazakou P, Psaltopoulou T, Vasileiou V, Paschou SA. Elevated FIB-4 is Associated with higher rates of Cardiovascular Disease and Extrahepatic Cancer History in patients with type 2 diabetes Mellitus. Biomedicines. 2024;12:823.

Karagiannakis DS, Markakis G, Lekakis V. Evaluation of spleen stiffness by 2D shear wave elastography for ruling out high risk varices in patients with chronic advanced liver disease. A systematic review and meta-analysis. European Journal of Radiology. 2024:111475.

Pyrgioti EE, Karakousis ND, Georgakopoulos PN, Karagiannakis DS, Papanas N. Folic Acid and Diabetic Foot Ulcers. The International Journal of Lower Extremity Wounds. 2024:15347346241226677.

Stefanaki K, Karagiannakis DS, Peppa M, Vryonidou A, Kalantaridou S, Goulis DG, Psaltopoulou T, Paschou SA. Food Cravings and Obesity in Women with Polycystic Ovary Syndrome: Pathophysiological and Therapeutic Considerations. Nutrients. 2024;16:1049.

Karagiannakis DS. Transjugular intrahepatic portosystemic shunt for recompensating decompensated cirrhosis?. World Journal of Gastroenterology. 2024;30:2621.

Karagiannakis DS. Percutaneous transhepatic cholangiography: An effective option for endo-biliary radiofrequency ablation before stent insertion in unresectable biliary cancer?. World Journal of Clinical Cases. 2024;12:6413.

Gerontiti E, Shalit A, Stefanaki K, Kazakou P, Karagiannakis DS, Peppa M, Psaltopoulou T, Paschou SA. The role of low glycemic index and load diets in medical nutrition therapy for type 2 diabetes: an update. Hormones. 2024:1–11.

Karakousis ND, Pyrgioti EE, Georgakopoulos PN, Karagiannakis DS, Papanas N. Vitamin E and diabetic foot ulcers. Current Diabetes Reviews. 2024;20:29–32.

Stefanaki K, Karagiannakis D, Foteini P, Zacharaki P, Giannou A, Michalopoulou O, Kazakou P, Psaltopoulou T, Vasileiou V, Paschou S. The development of cardiovascular disease or cancer is correlated with higher FIB-4 in patients with T2DM. In: Endocrine Abstracts. Vol. 99. Bioscientifica; 2024.

Zaimi M, Michalopoulou O, Stefanaki K, Kazakou P, Vasileiou V, Psaltopoulou T, Karagiannakis DS, Paschou SA. Gonadal dysfunction in women with diabetes mellitus. Endocrine. 2024;85:461–472.

Karakousis N, Pyrgioti E, Karagiannakis D, Georgakopoulos P, Alexiou K, Papanas N. Hand grip strength and diabetic foot ulcers: A mini-review. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2024;31:356–362.

Roussos S, Bagos C, Angelopoulos T, Chaikalis S, Cholongitas E, Savvanis S, Papadopoulos N, Kapatais A, Chounta A, Ioannidou P, et al. Incidence of primary hepatitis C infection among people who inject drugs during 2012–2020 in Athens, Greece. Journal of Viral Hepatitis. 2024;31:466–476.

Androutsakos T, Tsantzali I, Karagiannakis DS, Flevari P, Iakovou D, Pouliakis A, Kykalos S, Doris S, Xyla V. Peripheral Neuropathy in Patients with Hepatitis C Infection—Reversibility after HCV Eradication: A Single Center Study. Viruses. 2024;16:522.

Papatheodoridi M, Sevastianos V, Zachou K, Christodoulou D, Koskinas I, Deutsch M, Alexopoulou A, Elefsiniotis I, Triantos C, Gigi E, et al. WED-403 HEllenic multicenter ReAl-life CLInical Study for bulevirtide therapy in chronic hepatitis D (HERACLIS\_BLV\_D). Journal of Hepatology. 2024;80:S798–S799.

Voulgaris T, Tiniakos D, Karagiannakis D, Myoteri D, Karandrea D, Manolakopoulos S, Papatheodoridis G, Vlachogiannakos J. Alteration of small intestinal occludin and ZO-1 expession in liver cirrhosis. Pathology International. 2024;74:154–156.

Roussos S, Angelopoulos T, Cholongitas E, Savvanis S, Papadopoulos N, Kapatais A, Chounta A, Ioannidou P, Deutsch M, Manolakopoulos S, et al. High levels of all-cause mortality among people who inject drugs from 2018 to 2022. International Journal of Drug Policy. 2024;126:104356.

Karagiannakis DS, Karakousis ND, Androutsakos T. B-blockers in liver cirrhosis: A wonder drug for every stage of portal hypertension? A narrative review. Biomedicines. 2023;12:57.

Stefanaki K, Ilias I, Paschou SA, Karagiannakis DS. Hepatokines: the missing link in the development of insulin resistance and hyperandrogenism in PCOS?. Hormones. 2023;22:715–724.

Karagiannakis DS, Stefanaki K, Raftopoulou M, Psaltopoulou T, Paschou SA, Ilias I. Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome. 2023.

Karagiannakis DS, Stefanaki K. Spleen stiffness: a predictive factor of dismal prognosis in liver cirrhosis. Clinical Journal of Gastroenterology. 2023;16:121–129.

Tolaymat A, Goubau C, Adeyinka A, Kourek C, Mekkawy AH, Maciej C, Mart{\'ınez-Rodr{\'ıguez A, Akman CI, Morka A, Giraudo C, et al. Acknowledgment to the Reviewers of Pediatric Reports in 2022. 2023.

Koukoubanis K, Stefanaki K, Karagiannakis DS, Kalampalikis A, Michala L. Comparison of salivary cortisol levels between women with functional hypothalamic amenorrhea and healthy women: a pilot study. Endocrine. 2023;82:399–405.

Stefanaki K, Karagiannakis DS, Raftopoulou M, Psaltopoulou T, Paschou SA, Ilias I. Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome. Endocrine. 2023;82:201–208.

Karagiannakis DS. Systemic treatment in intermediate stage (Barcelona Clinic Liver Cancer-B) hepatocellular carcinoma. Cancers. 2023;16:51.

Karagiannakis DS, Voulgaris T, Markakis G, Lakiotaki D, Michailidou E, Cholongitas E, Papatheodoridis G. Spleen stiffness can predict liver decompensation and survival in patients with cirrhosis. Journal of Gastroenterology and Hepatology. 2023;38:283–289.

Papatheodoridis G, Mimidis K, Manolakopoulos S, Triantos C, Vlachogiannakos I, Veretanos C, Deutsch M, Karatapanis S, Goulis I, Elefsiniotis I, et al. HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patients. Liver International. 2023;43:1879–1889.

Stefanaki A, Karagiannakis D, Georgiopoulos G, Michala L, Ilias I, Vlachogiannakos J, Papatheodoridis G, Mastorakos G. Obesity, insulin resistance and hyperandrogenism are implicated in the progression of liver stiffness (LS) in women with PCOS. In: Endocrine Abstracts. Vol. 90. Bioscientifica; 2023.

Markakis GE, Karagiannakis D, Poulia KA, Lakiotaki D, Elisavet M, Giannakodimos I, Sakka D, Papatheodoridis GV, Cholongitas E. Psoas muscle index: new tool for diagnosing sarcopenia in patients with decompensated cirrhosis?. Clinical Nutrition ESPEN. 2023;54:520.

Bampatsias D, Dimopoulou M-A, Karagiannakis D, Sianis A, Korompoki E, Kantreva K, Psimenou E, Trakada G, Papatheodoridis G, Stamatelopoulos K. SARS-CoV-2 infection-related deregulation of blood lipids in a patient with-/-LDLR familial homozygous hypercholesterolemia: A case report. Journal of Clinical Lipidology. 2023;17:219–224.

Karagiannakis DS, Markakis G, Lakiotaki D, Cholongitas E, Vlachogiannakos J, Papatheodoridis G. Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease. European journal of gastroenterology & hepatology. 2022;34:961–966.

Cholongitas E, Tsilingiris D, Diamantopoulou P, Mastrogianni E, Tentolouris A, Karagiannakis D, Moyssakis I, Papatheodoridis GV, Tentolouris NIKOLAOS. Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease. Hormones. 2022:1–13.

Karagiannakis D, Markakis G, Lakiotaki D, Michailidou E, Fytili P, Cholongitas E, Vlachogiannakos I, Papatheodoridis G. Correlations of 2D-Shear wave and transient elastography liver stiffness measurements in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 2022;77:S429.

Papatheodoridis GV, Mimidis K, Manolakopoulos S, Triantos CU, Vlachogiannakos I, Veretanos C, Deutsch M, Karatapanis S, Goulis I, Elefsiniotis IS, et al. FACTORS OF UNDERDIAGNOSIS AND PREVALENCE OF HEPATITIS D VIRUS (HDV) INFECTION IN HBsAg-POSITIVE PATIENTS: A HELLENIC MULTICENTER REAL-LIFE CLINICAL STUDY (HERACLIS-HDV). In: HEPATOLOGY. Vol. 76. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2022. pp. S293–S294.

Rousssos S, Angelopoulos T, Cholongitas E, Savvanis S, Papadopoulos N, Kapatais A, Hounta A, Ioannidou P, Deutsch M, Manolakopoulos S, et al. High levels of all-cause mortality among people who inject drugs in Greece in 2018–2022. medRxiv. 2022:2022–10.

Karagiannakis DS, Voulgaris T, Angelopoulos T, Ioannidou P, Cholongitas E, Vlachogiannakos J, Papatheodoridis GV. Comparative utility of transient and 2D shear wave elastography for the assessment of liver fibrosis in clinical practice. Journal of Digital Imaging. 2021;34:1342–1348.

Vlachogiannakos J, Binas J, Siakavellas S, Karagiannakis DS, Voulgaris T, Papatheodoridis GV, Ladas SD. Platelet activation and hypercoagulability in patients with early primary biliary cholangitis compared with healthy controls. Annals of Gastroenterology. 2021;34:229.

Voulgaris TA, Karagiannakis D, Hadziyannis E, Manolakopoulos S, Karamanolis GP, Papatheodoridis G, Vlachogiannakos J. Serum zonulin levels in patients with liver cirrhosis: Prognostic implications. World Journal of Hepatology. 2021;13:1394.

Karagiannakis DN, Iatridou KI, Mandalidis DG. Ankle muscles activation and postural stability with Star Excursion Balance Test in healthy individuals. Human movement science. 2020;69:102563.

Sypsa V, Kalamitsis G, Cholongitas E, Savvanis S, Papadopoulos N, Chounta A, Kapatais A, Ioannidou P, Deutsch M, Manolakopoulos S, et al. Factors associated with failure to link people who inject drugs to HCV care and treatment: results from a community-based seek-test-treat program in Athens, Greece (ARISTOTLE HCV-HIV). Journal of Hepatology. 2020;73:S830.

Vlachogiannakos J, Papadomichelakis M, Karamanolis G, Karlaftis A, Voulgaris T, Karagiannakis D, Papatheodoridis G, Ladas SD. Tu1720 ADRENAL INSUFFICIENCY IN CIRRHOTIC PATIENTS WITH STABLE DISEASE. THE ROLE OF BACTERIAL TRANSLOCATION. Gastroenterology. 2020;158:S–1469.

Voulgaris T, Karagiannakis D, Siakavellas S, Kalogera D, Angelopoulos T, Chloupi E, Karamanolis G, Papatheodoridis G, Vlachogiannakos J. High prevalence of asymptomatic peptic ulcers diagnosed during screening endoscopy in patients with cirrhosis. Annals of gastroenterology. 2019;32:451.

Sypsa V, Kalamitsis G, Cholongitas E, Savvanis S, Papadopoulos N, Chounta A, Kapatais A, Ioannidou P, Deutsch M, Manolakopoulos S, et al. IMPROVING ACCESS TO HCV CARE FOR PEOPLE WHO INJECT DRUGS THROUGH A COMMUNITY-BASED PROGRAM IN ATHENS, GREECE (ARISTOTLE HCV-HIV). In: HEPATOLOGY. Vol. 70. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2019. pp. 347A–348A.

Karagiannakis DS, Voulgaris T, Koureta E, Chloupi E, Papatheodoridis GV, Vlachogiannakos J. Role of spleen stiffness measurement by 2D-shear wave elastography in ruling out the presence of high-risk varices in cirrhotic patients. Digestive Diseases and Sciences. 2019;64:2653–2660.

Vlachogiannakos J, Karagiannakis D, Voulgaris T, Siakavellas SI, Angelopoulos T, Karamanolis G, Papatheodoridis G. Su1090–The Role of Zonulin in Bacterial Translocation and in the Prognosis of Patients with Liver Cirrhosis. Gastroenterology. 2019;156:S–1273.

Vlachogiannakos J, Voulgaris T, Karagiannakis D, Papageorgiou M-V, Ioannidou P, Karamanolis G, Papatheodoridis G. Tu1586–Do Ppis Affect the Incidence of Liver-Related Complications and Overall Survival in Patients with Cirrhosis? the Experience of a Greek Tertiary Hospital. Gastroenterology. 2019;156:S–1369.

Georgiou A, Vlahogiannakos I, Karagiannakis D, Deutsch M, Alexopoulou A, Ioannidou P, Papageorgiou M, Prapa A, Papatheodoridis G, Kontogianni M. Prevalence of sarcopenia and diagnostic ability assessment of widely available methods of muscle mass and performance estimation in cirrhotic patients. Clinical Nutrition ESPEN. 2018;24:185–186.

Vlachogiannakos J, Voulgaris T, Karagiannakis D, Kalogera D, Angelopoulos T, Choupi E, Karamanolis G, Papatheodoridis G. Tu1562-Increased Frequency of Peptic Ulcers Diagnosed During Screening Endoscopy in Asymptomatic Patients with Advanced Chronic Liver Disease. Gastroenterology. 2018;154:S–1252.

Karagiannakis D, Voulgaris TA, Siakavellas S, Angelopoulos T, Kalogera D, Vlachogiannakos I, Papatheodoridis GV. An External Validation of the Baveno VI and Expanded Baveno VI Criteria Using Shear-Wave Elastography (SWE) Instead of Transient Elastography. In: HEPATOLOGY. Vol. 68. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 489A–490A.

Voulgaris TA, Karagiannakis D, Angelopoulos T, Kalogera D, Siakavellas S, Vlachogiannakos I, Papatheodoridis GV. Share Wave Elastography (SWE) of Spleen for Prediction of High Risk Varices in Patients with Advanced Compensated Cirrhosis. In: HEPATOLOGY. Vol. 68. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 486A–486A.

Karagiannakis DS, Voulgaris T, Siakavellas SI, Papatheodoridis GV, Vlachogiannakos J. Evaluation of portal hypertension in the cirrhotic patient: hepatic vein pressure gradient and beyond. Scandinavian journal of gastroenterology. 2018;53:1153–1164.

Georgiou A, Papatheodoridis G, Deutsch M, Alexopoulou A, Vlachogiannakos J, Ioannidou P, Papageorgiou M-V, Papadopoulos N, Karagiannakis D, Papavdi M, et al. Evaluation of two nutrition screening tools in predicting malnutrition, sarcopenia and one-year survival In cirrhotic patients. Clinical Nutrition. 2018;37:S64.

Georgiou A, Prapa A, Papatheodoridis G, Deutsch M, Alexopoulou A, Vlachogiannakos J, Ioannidou P, Papageorgiou M-V, Papadopoulos N, Karagiannakis D, et al. Prevalence of malnutrition in a sample of cirrhotic patients. Clinical Nutrition. 2018;37:S63–S64.

Manolakopoulos S, Sevastianos V, Triantafyllou K, Goulis I, Cholongitas E, Oikonomopoulou M, Karaoulani T, Dalekos GN, Samonakis D, Deutsch M, et al. Sofosbuvir/Velpatasvir (SOF/VEL)+/-Ribavirin (RBV) in the Treatment of Genotype 3 (GT3) Chronic Hepatitis C (CHC) Patients. Heraclis: A Hellenic Multicenter Real-Life Cohort Clinical Study. In: Hepatology. Vol. 68. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2018. pp. 378A–379A.

Vlachogiannakos J, Karagiannakis D, Voulgaris T, Siakavellas SI, Kalogera D, Angelopoulos T, Choupi E, Manolakopoulos S, Papatheodoridis G. Tu1558-An External Validation of the Baveno VI and Expanded Baveno VI Criteria on Attempting to Transform them into a One Stop Liver Shop. Gastroenterology. 2018;154:S–1250.

Vlachogiannakos J, Manolakopoulos S, Samonakis DN, Koskinas J, Papageorgiou M-V, Ketikoglou I, Oikonomopoulou M, Elefsiniotis IS, Goulis I, Vasileiadis TG, et al. Efficacy and safety of treatment with direct acting antiviral (s) in Chronic Hepatitis C (CHC) patients with compensated advanced liver disease and signs of portal hypertension. HERACLIS: a Hellenic multicenter real-life cohort clinical study. In: HEPATOLOGY. Vol. 66. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2017. pp. 813A–814A.

Papatheodoridis G, Kapatais A, Sinakos E, Elefsiniotis I, Goulis J, Deutsch M, Vlachogiannakos J, Dalekos G, Koskinas J, Karatapanis S, et al. Platelets represent an independent predictor of sustained virological response (SVR) in patients with advanced chronic hepatitis C (CHC) treated with current direct acting antiviral (s)(DAA). HERACLIS: Hellenic multicenter real-life cohort study. Journal of Hepatology. 2017;66:S502.

Dalekos G, Vlachogiannakos J, Manesis EK, Goulis I, Mimidis K, Oikonomopoulou M, Ioannidou P, Kourikou A, Gatselis NK, Papageorgiou M-V, et al. Regression of liver stiffness following therapy with direct acting antiviral (s) in chronic hepatitis C patients. Results from HERACLIS: a Hellenic multicenter real-life cohort clinical study. In: HEPATOLOGY. Vol. 66. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2017. pp. 619A–619A.

Manolakopoulos S, Akriviadis E, Vlachogiannakos J, Papageorgiou M-V, Kapatais A, Oikonomopoulou M, Vasileiadis TG, Manesis EK, Karatapanis S, Deutsch M, et al. The impact of direct acting antivirals (DAAs) in patients with decompensated liver disease (DLD) due to chronic hepatitis C (CHC). heraclis-a multicenter greek real world study. In: Hepatology. Vol. 66. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2017. pp. 838A–839A.

Papatheodoridis G, Manolakopoulos S, Kapatais A, Sinakos E, Elefsiniotis I, Goulis J, Deutsch M, Vlachogiannakos J, Dalekos G, Koskinas J, et al. Predictors of sustained virological response (SVR) in patients with advanced chronic hepatitis C (CHC) treated with current direct acting antiviral (s)(DAA). Heraclis: Hellenic multicenter real-life cohort study. Gastroenterology. 2017;152:S1093.

Voulgaris T, Vlachogiannakos J, Ioannidou P, Papageorgiou M-V, Zampeli E, Karagiannakis D, Georgiou A, Papazoglou A, Karamanolis G, Papatheodoridis GV. Adherence to follow-up and treatment recommendations in Greek and immigrant patients with chronic hepatitis B in Greece. European journal of gastroenterology & hepatology. 2017;29:264–270.

Papatheodoridis GV, Koskinas J, Goulis I, Sinakos E, Dalekos G, Kapatais A, Oikonomopoulou M, Vlachogiannakos J, Elefsiniotis IS, Deutsch M, et al. Changes in the use of direct acting antiviral (s)(DAA) in the treatment of chronic hepatitis C (CHC) patients in clinical practice. HERACLIS: a Hellenic multicenter real-life cohort clinical study. In: Hepatology. Vol. 66. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2017. pp. 603A–604A.

Goulis I, Elefsiniotis I, Karatapanis S, Koskinas J, Ioannidou P, Manolakopoulos S, Vlachogiannakos J, Oikonomopoulou M, Samonakis DN, Manesis EK, et al. High efficacy of the currently recommended regimens of 2 Direct Acting Antivirals (DAAs)+/-Ribavirin (R) in HCV genotype 4 (GT4) patients (pts) with advanced fibrosis or cirrhosis in HERACLIS real world cohort. In: HEPATOLOGY. Vol. 66. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2017. pp. 815A–816A.

Kaltsa G, Bamias G, Siakavellas SI, Goukos D, Karagiannakis D, Zampeli E, Vlachogiannakos J, Michopoulos S, Vafiadi I, Daikos GL, et al. Systemic levels of human $\beta$-defensin 1 are elevated in patients with cirrhosis. Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of Gastroenterology. 2016;29:63.

Koskinas J, Deutsch M, Ioannidou P, Manolakopoulos S, Cholongitas E, Rigopoulou EI, Schina MJ, Sevastianos VA, Elefsiniotis LS, Goulis J, et al. Efficacy and safety of direct acting antiviral (s)(DAA) containing regimens in the treatment of chronic hepatitis C (CHC) patients with genotype 3. A real life experience. In: Hepatology. Vol. 63. WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2016. pp. 1007A–1008A.

Elefsiniotis LS, Dalekos GN, Koskinas J, Ioannidou P, Cholongitas E, Manolakopoulos S, Goulis J, Vlachogiannakos J, Deutsch M, Triantos CK, et al. Daclatasvir (DCV) plus Sofosbuvir (SOF) regimens in chronic Hepatitis C Virus (HCV) infected patients with advanced fibrosis or cirrhosis. In: HEPATOLOGY. Vol. 64. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2016. pp. 990A–991A.

Vlachogiannakos J, Kapatais A, Elefsiniotis IS, Koskinas J, Papageorgiou M-V, Manolakopoulos S, Gatselis N, Cholongitas E, Deutsch M, Karatapanis S, et al. Efficacy and safety of ombitasvir (OBV) and ritonavir boosted paritaprevir (PRV/r) with or without dasabuvir (DSV) regimens in genotype 1 or 4 HCV infected patients. A Greek multicenter real-life cohort study. In: HEPATOLOGY. Vol. 64. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2016. pp. 998A–998A.

Papatheodoridis GV, Kapatais A, Goulis I, Elefsiniotis IS, Vlachogiannakos J, Manolakopoulos S, Dalekos GN, Koskinas J, Karatapanis S, Ketikoglou I, et al. Efficacy and safety of the currently recommended regimens with direct acting antiviral (s)(DAA) in the treatment of chronic hepatitis C (CHC) patients in clinical practice. A Greek multicenter real-life cohort study. In: HEPATOLOGY. Vol. 64. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2016. pp. 977A–977A.

Varbobitis IC, Siakavellas SI, Koutsounas IS, Karagiannakis DS, Ioannidou P, Papageorgiou M-V, Pavlopoulou ID, Schizas D, Bamias G, Vlachogiannakos I, et al. Reliability and applicability of two-dimensional shear-wave elastography for the evaluation of liver stiffness. European journal of gastroenterology & hepatology. 2016;28:1204–1209.

Sinakos E, Ketikoglou I, Koskinas J, Kapatais A, Ioannidou P, Goulis J, Manolakopoulos S, Manesis EK, Vlachogiannakos J, Deutsch M, et al. Safety and efficacy of regimens including direct acting antivirals (DAAs) in chronic hepatitis C (CHC) patients over the age of 70 years. In: HEPATOLOGY. Vol. 64. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA; 2016. pp. 983A–984A.

Karagiannakis DS. George Papatheodoridis & Jiannis Vlachogiannakos. Dig Dis Sci. 2015;60:1141–1151.

Karagiannakis DS, Papatheodoridis G, Vlachogiannakos J. Recent advances in cirrhotic cardiomyopathy. Digestive diseases and sciences. 2015;60:1141–1151.

Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD. Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis. Hepatology international. 2014;8:588–594.

Perperas A, Karagiannakis D, Anagnostopoulos G, Tsirogiannis A, Panagiotakos D, Papadopoulos S, Tsagkaris M, Papasteriades C, Manolakopoulos S. Pretreatment serum interleukin-12 levels in predicting sustained virological response among hepatitis C patients following Pegylated Interferon-$\alpha$2$\beta$ plus Ribavirin treatment. Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of Gastroenterology. 2013;26:249.

Vlachogiannakos J, Karagiannakis D, Anastasiadis G, Karlaftis A, Vafiadis-Zouboulis I, Ladas SD. Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis: 1329. Hepatology. 2013;58:854A.

Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafiadis-Zouboulis I, Ladas SD. Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Digestive diseases and sciences. 2013;58:3029–3036.

Kaltsa G, Zouboulis-Vafiadis I, Gizis M, Karagiannakis DS, Laoudi E, Vlachogiannakos J, Daikos G, Bamias G, Ladas SD. 169 Markers of Bacterial Translocation in Patients With Chronic Liver Disease. Gastroenterology. 2012;142:S–42.

Karagiannakis DS, Vlachogiannakos J, Anastasiadis G, Vafladi-Zoumbouli I, Ladas SD. 630 THE ROLE OF BACTERIAL TRANSLOCATION ON THE DEVELOPMENT AND THE SEVERITY OF CIRRHOTIC CARDIOMYOPATHY. Journal of Hepatology. 2012;56:S250.

Kaltsa G, Vafiadis-Zouboulis I, Karagiannakis D, Vlachogiannakos J, Siakavellas SI, Gizis M, Zampeli E, Michopoulos S, Daikos GL, Bamias G, et al. ELEVATED PLASMA LEVELS OF NATURAL ANTIMICROBIAL PEPTIDES IN PATIENTS WITH CHRONIC LIVER DISEASE: 1930. Hepatology. 2011;54:1270A.

Karagiannakis D, Vlachogiannakos J, Anastasiadis G, Kaltsa G, Siakavellas SI, Vafiadis-Zouboulis I, Ladas SD. CIRRHOTIC CARDIOMYOPATHY: FREQUENCY, CHARACTERISTICS AND RELATIONSHIP WITH BACTERIAL TRANSLOCATION: 1883. Hepatology. 2011;54:1248A.